Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 5,294,615

« Back to Dashboard

Summary for Patent: 5,294,615

Title: Terazosin polymorph and pharmaceutical composition
Abstract:A novel anhydrous crystalline polymorph of 1-(4-amino-6,7-dimethoxy- 2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine monohydrochloride is disclosed, together with pharmaceutical formulations containing the compound. The novel polymorph exhibits a diminished food effect when administered to human subjects.
Inventor(s): Meyer; Glenn A. (Waukegan, IL), Bauer; John F. (Lake Bluff, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:08/090,721
Patent Claim Types:
see list of patent claims
Compound; Composition; Dosage form; Use;
Patent PDF download available with subscription

No matches for this query

International Patent Family for Patent: 5,294,615

Country Document Number Publication Date
Austria130853Dec 15, 1995
Austria182592Aug 15, 1999
Canada2107382Oct 30, 1994
Canada2143974Nov 21, 1995
Germany623612Aug 24, 1995
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc